Anthony Grosso has been appointed as the new head of scientific affairs at Accord Healthcare Europe.
In his new role he will be responsible for overseeing Accord’s strategy for sustained patient access to innovative, added-value, cost-effective and critical medicines, and will report to James Burt executive vice-president, Europe and MENA at Accord.
Dr Grosso is a registered pharmacist with a First-Class BSc (Hons) from Brighton, an MSc with Distinction from Belfast and a PhD from London, and has a long-standing interest in the efficient use of medicines, in particular with biologics, generics and biosimilars, which has led to him authoring numerous publications in these areas.
“We are thrilled to have Anthony join our senior team at Accord,” said Dr Burt. “There is a real opportunity to improve patient access to high quality medicines and for generics companies like us to drive the development of added-value medical innovations – we are always looking to make it better for healthcare systems and ultimately patients. Anthony’s experience in running pharmaceutical businesses and his time at the coal-face of pharmacy delivery will help us achieve these goals and adds to our burgeoning team of generics and biosimilar specialists.”